Ty J. Young Wealth Management Produces Video Guide For Retirement Investors
ATLANTA, May 6, 2024 /PRNewswire/ -- Leading financial advisory firm, Ty J. Young Wealth Management, has produced a video guide to help investors who have questions about navigating their retirement strategy.
Amidst the current backdrop of uncertainty in the economy and financial markets, Ty J. Young Wealth Management provides its clients with the support and tools to help protect their retirement nest egg while earning a reasonable rate of return. The video guide features CEO Ty Young explaining how the firm helps clients achieve their retirement goals.
As investors think about their long term wealth goals and retirement planning, the investors guide video will give them a starting point for choosing a strategy that suits their lifestyle.
Ty J. Young Wealth Management is one of America's largest independent wealth management firms. Founded by Ty J. Young in 1998, the firm manages more than $1 billion in assets for more than 7,000 clients nationwide. They are recognized as a thought leader in investment management, retirement planning and insurance with Ty Young frequently being featured on CNBC, Forbes, Fox Business and more. Learn more about Ty J. Young Wealth Management at: https://www.tyjyoung.com/
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...